The global Salmonella Testing Market is estimated to be
valued at US$ 2.91 billion in 2023
and is expected to exhibit a CAGR of
7.8% over the forecast period 2023-2030,
as highlighted in a new report published by Coherent Market Insights.



Market Overview:

Salmonella
Testing Demands plays a crucial role in ensuring food safety and preventing
salmonella infections. It involves the detection and identification of
salmonella bacteria in various food products and environmental samples. The
market offers a wide range of testing methods, including culture-based methods,
immunoassays, molecular diagnostics, and others. These testing methods are used
by food manufacturers, regulatory bodies, and research institutions to ensure
the quality and safety of food products. The increasing awareness about foodborne
illnesses and the rising incidence of salmonella infections are driving the
growth of the Salmonella Testing Market.



Market Dynamics:

1.      Driver:
Increasing Awareness about Food Safety

With growing concerns about foodborne illnesses, there is an increased emphasis
on food safety and quality. Consumers are becoming more conscious about the
sources and handling of food products. This has prompted governments and
regulatory bodies to implement strict regulations and testing protocols to
ensure the safety of food products. Additionally, food manufacturers are
adopting advanced testing methods to comply with these regulations and
safeguard their brand reputation.



2. Opportunity: Rising Incidence of
Salmonella Infections

Salmonella infections are a significant public health concern worldwide. The
Centers for Disease Control and Prevention (CDC) estimates that salmonella
causes approximately 1.35 million
infections, 26,000 hospitalizations,
and 420 deaths in the United States each year. The increasing prevalence of
salmonella infections has created a demand for accurate and efficient testing
methods to identify and control the spread of the bacteria. This presents a
significant opportunity for market players to develop innovative testing
solutions.



Segment Analysis:

The molecular diagnostics segment is expected to dominate the Salmonella
Testing Market during the forecast period. This is attributed to the advantages
offered by molecular testing methods, such as faster turnaround time, high
sensitivity, and specificity. The ability of molecular diagnostics to detect
multiple strains of salmonella bacteria further contributes to their market
dominance. Additionally, the increasing adoption of molecular testing by
laboratories and food manufacturers is driving the growth of this segment.



PEST Analysis:

- Political:
Governments worldwide are implementing stringent regulations and standards for
food safety, which are driving the demand for salmonella testing.

- Economic: The growing global population, increasing urbanization, and rising
disposable incomes are fueling the demand for safe and quality food products,
thereby driving the growth of the Salmonella Testing Market.



- Social: The increasing awareness about foodborne illnesses and the importance
of food safety among consumers is influencing their purchasing behavior and
driving the demand for salmonella testing.



- Technological: Advances in testing technologies, such as rapid and automated
testing methods, are enhancing the efficiency and accuracy of salmonella
testing.



Key Takeaways:

- The global Salmonella Testing Market is expected to witness high growth,
exhibiting a CAGR of 7.8% over the
forecast period, due to increasing awareness about food safety and the rising
incidence of salmonella infections.



- North America is expected to dominate the market during the forecast period,
owing to the stringent regulatory framework and high awareness about food
safety in the region.



- Key players operating in the global Salmonella Testing Market include Thermo
Fisher Scientific, Merck KGaA (known as MilliporeSigma in the United States and
Canada), bioMérieux SA, Neogen Corporation, QIAGEN N.V., 3M Company,
PerkinElmer Inc., Romer Labs Division Holding GmbH, Eurofins Scientific, Hardy
Diagnostics, Charles River Laboratories International Inc., LabCorp, R-Biopharm
AG, Biomerica Inc., and Zeulab S.L.



In conclusion, the global Salmonella Testing Market is poised for significant
growth, driven by the increasing awareness about food safety and the rising
incidence of salmonella infections. The market offers lucrative opportunities
for players to develop innovative testing solutions and cater to the growing
demand for accurate and efficient salmonella testing methods.